Efficacy of Combined Anodal tDCS over M1 and F3 Regions in Diabetic Neuropathic Pain: Double-blind Randomized Controlled Study.
Not Applicable
Not yet recruiting
- Conditions
- Nervous System DiseasesNutritional, Metabolic, Endocrine
- Registration Number
- PACTR202405874828622
- Lead Sponsor
- Ain Shams University Faculty of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
•Type-2 diabetes and neuropathic pain, at least 5 years of diabetes history
•Aged 45 to 65 years,
•Ability and willingness to participate in intervention sessions.
Exclusion Criteria
•Use of strong painkillers
•Not suffering from any medical conditions (such as a herniated disc, or injuries from a serious accident that took place within the previous three months) that induce neuropathic and chronic pain
•History of head or neck surgery.
•Use of a cardiac pacemaker or defibrillator
•Subjects with diabetic foot ulcers and amputation were excluded from the study. Diabetic subjects with stroke.
• Absence in more than two sessions or more than four days between sessions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method